Clinical perspectives and therapeutics of thrombolysis (Q35559711)

8 August 2017

1 reference

title

Clinical perspectives and therapeutics of thrombolysis (English)

1 reference

Cardiology and cardiovascular medicine

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00019-6

21 March 2024

author name string

Ijaz A. Khan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559121

21 March 2024

Ramesh M. Gowda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559121

21 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14559121

21 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0167527303000196?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00019-6

https://api.elsevier.com/content/article/PII:S0167527303000196?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00019-6

International Journal of Cardiology

21 March 2024

published in

1 reference

8 August 2017

91

1 reference

8 August 2017

2-3

1 reference

8 August 2017

115-127

1 reference

Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Remodelling of the heart after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Segmental perfusion of the coronary arteries with fibrinolysin in man following a myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Intravenous short-term infusion of streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Intravenous streptokinase in evolving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

TIMI frame count: a quantitative method of assessing coronary artery flow

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Use of thrombolytic therapy for acute myocardial infarction: effects of gender and age on treatment rates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Cost and quality of life: thrombolysis and primary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

The St. Jude valve. Thrombolysis as the first line of therapy for cardiac valve thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Early intervention in massive pulmonary embolism. A guide to diagnosis and triage for the critical first hour

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Innovative strategies in the management of acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Combination therapy in peripheral vascular disease: the rationale of using both thrombolytic and antiplatelet drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Reperfusion revisited: beyond TIMI 3 flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

The need for wider utilization of thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Cost effectiveness of tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Tailored thrombolytic therapy. A perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

Benefit of late coronary reperfusion in patients with acute myocardial infarction and persistent ischemic chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900019-6

7 January 2021

The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy

6

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00019-6

Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes

21 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00019-6

The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography

21 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00019-6

21 March 2024

Identifiers

1 reference

8 August 2017

1 reference